Inventor · disambiguated record
Matthew Russell Netherton
Also filed as: NETHERTON MATTHEW · NETHERTON MATTHEW R · NETHERTON MATTHEW RUSSELL
22 granted patents·17 pending applications·171 citations·filing 2004–2023
95Inventor score
Files withFOGHORN THERAPEUTICS INC18BOEHRINGER INGELHEIM PHARMA8BOEHRINGER INGELHEIM INT6TRIESELMANN THOMAS3ABEYWARDANE ASITHA2
Top patents by PatentIndex Score
39 records- 0195US11560381B1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Jan 24, 2023·12 cites·12 claims
- 0295US11414416B1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Aug 16, 2022·16 cites·15 claims
- 0395US7531560B2Anti-cytokine heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 12, 2009·23 cites·18 claims
- 0493US7514458B2Anti-cytokine heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Apr 7, 2009·25 cites·10 claims
- 0592US11787800B2BRD9 degraders and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·3 cites·24 claims
- 0692US11773085B2Methods and compounds for treating disordersFOGHORN THERAPEUTICS INC·Filed 2020·Granted Oct 3, 2023·10 cites·4 claims
- 0788US10898487B2Benzylamino substituted quinazolines and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jan 26, 2021·8 cites·19 claims
- 0888US7214802B2Anti-cytokine heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 8, 2007·12 cites·18 claims
- 0987US8551982B2Benzodioxane inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2012·Granted Oct 8, 2013·11 cites·42 claims
- 1083US12053473B2Benzylamino substituted quinazolines and derivatives as SOS1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 6, 2024·1 cites·5 claims
- 1183US9133146B2Benzodioxane inhibitors of leukotriene productionBOEHRINGER INGELHEIM INT·Filed 2013·Granted Sep 15, 2015·6 cites·5 claims
- 1281US7511042B2Triazole compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Mar 31, 2009·16 cites·15 claims
- 1381US7078419B2Cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jul 18, 2006·15 cites·16 claims
- 1480US8946203B2Benzodioxane inhibitors of leukotriene productionABEYWARDANE ASITHA·Filed 2013·Granted Feb 3, 2015·6 cites·16 claims
- 1580US7790712B2Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Sep 7, 2010·5 cites·5 claims
- 1676US7335657B2Cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Feb 26, 2008·2 cites·16 claims
- 1774US12351579B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·0 cites·18 claims
- 1871US2024150348A1Brd9 degraders and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1969US2024150328A1Methods and compounds for treating disordersFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2067US2023142883A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2165US2023066136A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2262US2025304596A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2361US2025302832A1Pyrazine derivatives and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2457US2024376121A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2554US2024024488A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2653US2023348452A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2752US11370771B2Inhibitors of TRPC6BOEHRINGER INGELHEIM INT·Filed 2019·Granted Jun 28, 2022·0 cites·10 claims
- 2851US2006276496A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 2951US2023150974A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3049US2008103138A1Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsTRIESELMANN THOMAS·Filed 2007·Application pending·0 cites
- 3148US12391686B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 19, 2025·0 cites·22 claims
- 3248US12384776B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 12, 2025·0 cites·17 claims
- 3348US2023065463A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3445US7754756B2Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Jul 13, 2010·0 cites·16 claims
- 3545US2007112033A1Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsTRIESELMANN THOMAS·Filed 2006·Application pending·0 cites
- 3642US2010190773A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3741US2008300290A1Novel Beta-Agonists, Process for Their Preparation and Their Use as MedicamentsWALTER RAINER·Filed 2006·Application pending·0 cites
- 3837US2008269281A1Novel Beta-Agonists, Method for Producing Them and Their Use as DrugsTRIESELMANN THOMAS·Filed 2006·Application pending·0 cites
- 3934US8729114B2Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-SBURKE MICHAEL J·Filed 2011·Granted May 20, 2014·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Russell Netherton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →